整合应激反应与药物性急性肾损伤:ATF4-STAT1-GBP2信号通路的激活参与其中
本研究探讨整合应激反应在药物性急性肾损伤(AKI)中的作用机制。研究发现ATF4在肾小管中显著上调并与肾功能障碍正相关,其通过激活STAT1-GBP2信号促进肾小管上皮细胞焦亡,而抑制ATF4可减轻炎症和损伤。
要点
- ATF4是药物性AKI中炎症的关键调节因子,与肾功能障碍正相关。
- ATF4通过激活STAT1-GBP2信号通路促进肾小管上皮细胞焦亡。
- 药物抑制或纳米生物制剂沉默ATF4可显著减轻肾脏炎症和损伤。
核心结论
- ATF4通过STAT1-GBP2信号通路促进药物性AKI中的肾小管上皮细胞焦亡,抑制ATF4可减轻肾脏炎症和损伤。
研究设计与样本
- 采用单细胞RNA测序、免疫组化、免疫荧光评估药物性AKI后肾小管上皮细胞变化,并通过RNA测序、基因组操作、转录组分析、荧光素酶报告基因、免疫共沉淀和Western blotting探讨机制,利用转基因小鼠模型和药物干预评估细胞命运。
主要发现
- ATF4在人和小鼠AKI模型的肾小管中显著上调,并与肾功能障碍正相关。
- 肾小管上皮细胞特异性敲除ATF4可显著改善肾功能障碍、炎症和线粒体凋亡,而ATF4激活则加剧这些病理特征。
- ATF4抑制通过抑制STAT1磷酸化及其与GBP2的相互作用,减弱NLRP3炎症小体激活,防止肾小管上皮细胞焦亡并改善肾功能。
- 药物抑制ATF4(使用优先筛选的整合应激反应拮抗剂ERMT1)或通过工程纳米生物制剂介导的肾小管上皮细胞沉默,均显著减少肾脏炎症和损伤。
临床怎么用
- 靶向ATF4-STAT1-GBP2信号通路可能为药物性AKI提供新的治疗策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
KEY POINTS: Integrated stress response promotes drug-induced AKI. Activating transcription factor 4 promoted tubular epithelial cell pyroptosis in drug-induced AKI by activating signal transducer and activator of transcription 1-guanylate-binding protein 2 signaling. BACKGROUND: Pyroptosis plays a critical role in eliminating pathogens and facilitating tissue repair; however, sustained pyroptosis-driven inflammation accelerates kidney injury and disease progression. Thus, elucidating the mechanisms governing pyroptosis is essential for developing effective therapies for inflammatory kidney diseases, such as AKI, which currently lacks specific treatment options. METHODS: Changes in tubular epithelial cells (TEC) after drug-induced AKI were assessed using single-cell RNA sequencing, immunohistochemistry, and immunofluorescence. Mechanistic insights were obtained through RNA sequencing, genomic manipulation, transcriptomic profiling, luciferase reporter assays, coimmunoprecipitation, and Western blotting. TEC fate was further evaluated using transgenic mouse models and pharmacological interventions. RESULTS: We identified activating transcription factor 4 (ATF4) as a key regulator of inflammation in drug-induced AKI. As the master regulator of the integrated stress response, ATF4 was markedly upregulated in renal tubules and positively correlated with kidney dysfunction in both human and murine AKI models. The specific deletion of ATF4 in TECs significantly ameliorated kidney dysfunction, inflammation, and mitochondrial apoptosis, whereas ATF4 activation exacerbated these pathological features. Mechanistically, ATF4 suppression inhibited signal transducer and activator of transcription 1 phosphorylation and disrupted its interaction with guanylate-binding protein 2, thereby attenuating NLR family pyrin domain-containing 3 inflammasome activation, preventing TECs' pyroptosis, and improving kidney function. Notably, inhibition of ATF4-either pharmacologically using our prioritized integrated stress response antagonist ERMT1 or through engineered nanobiologics-mediated silencing of TECs-significantly reduced renal inflammation and injury. CONCLUSIONS: ATF4 promoted pyroptosis in drug-induced AKI through signal transducer and activator of transcription 1-guanylate-binding protein 2 signaling.
引用
- Zhang H, Sun X, Shen Y, et al. Integrated Stress Response and Drug-Induced Acute Kidney Injury: Involvement of Activating ATF4-STAT1-GBP2 Signaling. J Am Soc Nephrol. 2026. PMID: 41563239. doi:10.1681/ASN.0000000984
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。